Dolby SVP Couling sells 6,667 shares at $64.89

Dolby Laboratories senior executive John D. Couling reported a sale of company stock.

Accepted by SEC EDGAR 02/04/2026 - 04:10 PM EST Learn about SEC filing dates

Rhea-AI Filing Summary

Dolby Laboratories senior executive John D. Couling reported a sale of company stock. On February 2, 2026, he sold 6,667 shares of Dolby Class A common stock at $64.885 per share. After this transaction, he beneficially owned 123,041 shares in total.

This total includes 55,114 shares of Class A common stock underlying restricted stock units. These restricted stock units are subject to forfeiture until they vest, meaning Couling’s ability to keep those shares depends on future vesting conditions being met.

Insider Trade Summary

Net Seller: 6,667 shares

Net Sell 1 txn

Insider Couling John D

Role SVP, Entertainment

Sold 6,667 shs ($433K)

Share of Position Sold 5.1%

Type	Security	Shares	Price	Value
Sale	Class A Common Stock	6,667	$64.885	$433K

Holdings After Transaction: Class A Common Stock — 123,041 shares (Direct)

Holdings Before and After: Class A Common Stock, 129,708 to 123,041 shares (Direct)

Footnotes (1)

1. F1. Shares held following the reported transaction includes 55,114 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Dolby Laboratories (DLB) report for John D. Couling?

Dolby reported that SVP, Entertainment John D. Couling sold 6,667 shares of Class A common stock. The sale occurred on February 2, 2026, and was reported on a Form 4 insider trading filing under SEC Section 16 reporting requirements.

At what price did John D. Couling sell Dolby (DLB) shares on February 2, 2026?

John D. Couling sold 6,667 Dolby Class A common shares at $64.885 per share. This per-share price is the transaction price disclosed in the Form 4 and is used to calculate the total dollar value of the reported sale.

How many Dolby (DLB) shares does John D. Couling own after the reported sale?

Following the reported sale, John D. Couling beneficially owns 123,041 Dolby Class A shares. This figure combines directly held stock and shares underlying restricted stock units that may be forfeited if vesting conditions are not satisfied in the future.

What portion of John D. Couling’s Dolby (DLB) holdings are restricted stock units?

Of the 123,041 Dolby shares reported as beneficially owned, 55,114 shares are underlying restricted stock units. These units represent a right to receive shares in the future and are subject to forfeiture until they fully vest according to their grant terms.

What role does John D. Couling hold at Dolby Laboratories (DLB)?

John D. Couling is reported as an officer of Dolby Laboratories with the title “SVP, Entertainment.” This senior leadership position is disclosed in the Form 4 and explains why his ownership and trades in Dolby stock must be reported as insider transactions.

Was John D. Couling’s February 2026 Dolby (DLB) trade a direct or indirect ownership transaction?

The Form 4 shows the 6,667 Dolby Class A shares sold were held with direct ownership. The ownership form field is marked “D,” indicating the transaction involved shares directly owned by John D. Couling rather than through an intermediary entity or account.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Couling John D

(Last) (First) (Middle)

C/O DOLBY LABORATORIES, INC.

1275 MARKET STREET

(Street)

SAN FRANCISCO CA 94103

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Dolby Laboratories, Inc. [ DLB ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	SVP, Entertainment

3. Date of Earliest Transaction (Month/Day/Year)
02/02/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A Common Stock	02/02/2026		S		6,667	D	$64.885	123,041(1)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Shares held following the reported transaction includes 55,114 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest.

	/s/ Daniel Rodriguez as Attorney-in-Fact for John Couling	02/04/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.